SPDR S&P Pharmaceuticals ETF
XPH
XPH
78 hedge funds and large institutions have $101M invested in SPDR S&P Pharmaceuticals ETF in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $112M → $101M (-$11.1M)
55% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 31
Holders
78
Holding in Top 10
–
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$8.58M | |
| 2 | +$1.19M | |
| 3 | +$687K | |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$539K |
| 5 |
IMC Chicago
Chicago,
Illinois
|
+$527K |
Top Sellers
| 1 | -$2.07M | |
| 2 | -$2.05M | |
| 3 | -$1.58M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.41M |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
-$1.35M |